Kathleen Long
Hematology & Oncology · Hiram, GANPI 1043215403
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.4% of the total across 123 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,202 and has fallen 95.2% since, to $58 in 2025. That places this record below the midpoint for hematology & oncology clinicians in GA, where the typical reported total is $4,479.
Across 123 payments — averaging $17.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$307
- Amgen$198
- Seagen Inc.$150
- AstraZeneca$147
- Genentech USA, Inc.$135
- AbbVie$118
- plus $1K from 25 others
What the payments were for
- Food & beverage$1,96193%
- Education$1387%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 25 | $307 |
| Amgen | 10 | $198 |
| Seagen Inc. | 9 | $150 |
| AstraZeneca(2 entities) | 9 | $147 |
| Genentech USA, Inc. | 8 | $135 |
| AbbVie | 4 | $118 |
| Novartis | 5 | $110 |
| Johnson & Johnson(2 entities) | 7 | $105 |
| E.r. Squibb & Sons, L.L.C. | 6 | $85 |
| Bristol Myers Squibb | 4 | $74 |
| Merck | 4 | $73 |
| Rigel Pharmaceuticals, Inc. | 3 | $69 |
| Sanofi | 4 | $67 |
| Regeneron Healthcare Solutions, Inc. | 2 | $49 |
| Incyte Corporation | 2 | $36 |
| Daiichi Sankyo Inc. | 2 | $36 |
| Clovis Oncology, Inc. | 2 | $35 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $35 |
| Tesaro, Inc. | 2 | $35 |
| Bayer | 2 | $31 |
| Deciphera Pharmaceuticals Inc. | 1 | $28 |
| Ipsen Biopharmaceuticals, Inc | 1 | $25 |
| Tersera Therapeutics LLC | 1 | $24 |
| Puma Biotechnology, Inc. | 1 | $21 |
| GSK | 1 | $20 |
| Partner Therapeutics, Inc. | 1 | $19 |
| Eisai Inc. | 1 | $18 |
| Verastem, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Array Biopharma Inc | 1 | $3 |
How this compares
$2,100 in reported general payments places this provider in the 35th percentile of 370 hematology & oncology providers in Georgia.
Other hematology & oncology in Hiram
- Aron KefelaHiram$591K
- Priya RudolphAthens$745K
- Chandar BhimaniConyers$483K
- Ticiana LealAtlanta$450K
- Steven McCuneMarietta$450K
- Jorge LeguizamoLawrenceville$409K
- Trevor FeinsteinFayetteville$341K
- Jigarkumar ParikhAugusta$267K
- Ajay NookaAtlanta$222K
- Abdullah KutlarAugusta$196K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.